• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4681712)   Today's Articles (3418)
For: Li F, Zhang H, Jiang L, Zhang W, Nie J, Feng Y, Yang M, Liu M. Dynamic NMR study and theoretical calculations on the conformational exchange of valsartan and related compounds. Magn Reson Chem 2007;45:929-36. [PMID: 17876862 DOI: 10.1002/mrc.2072] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/17/2023]
Number Cited by Other Article(s)
1
Kale KB, Shinde MASA, Patil RH, Ottoor DP. Exploring the interaction of Valsartan and Valsartan-Zn(ll) complex with DNA by spectroscopic and in silico methods. SPECTROCHIMICA ACTA. PART A, MOLECULAR AND BIOMOLECULAR SPECTROSCOPY 2022;264:120329. [PMID: 34481251 DOI: 10.1016/j.saa.2021.120329] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/30/2021] [Revised: 08/19/2021] [Accepted: 08/24/2021] [Indexed: 05/08/2023]
2
Balazs A, Davies N, Longmire D, Packer M, Chiarparin E. Nuclear magnetic resonance free ligand conformations and atomic resolution dynamics. MAGNETIC RESONANCE (GOTTINGEN, GERMANY) 2021;2:489-498. [PMID: 37904764 PMCID: PMC10539760 DOI: 10.5194/mr-2-489-2021] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/28/2021] [Accepted: 05/28/2021] [Indexed: 11/01/2023]
3
Martínez VR, Aguirre MV, Todaro JS, Ferrer EG, Williams PAM. Candesartan and valsartan Zn(ii) complexes as inducing agents of reductive stress: mitochondrial dysfunction and apoptosis. NEW J CHEM 2021. [DOI: 10.1039/d0nj02937h] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
4
Kiriakidi S, Chatzigiannis C, Papaemmanouil C, Tzakos AG, Mavromoustakos T. Exploring the role of the membrane bilayer in the recognition of candesartan by its GPCR AT1 receptor. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES 2019;1862:183142. [PMID: 31830465 DOI: 10.1016/j.bbamem.2019.183142] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/01/2019] [Revised: 11/13/2019] [Accepted: 11/28/2019] [Indexed: 01/20/2023]
5
Jiang H, Wang X, Cui X. Two distinct conformers of SAG investigated by solution NMR and variable-temperature experiments. J Pharm Biomed Anal 2019;166:83-89. [PMID: 30639932 DOI: 10.1016/j.jpba.2018.12.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2018] [Revised: 12/10/2018] [Accepted: 12/11/2018] [Indexed: 10/27/2022]
6
de Oliveira RS, Boffo EF, Reis FC, Nikolaou S, Andriani KF, Caramori GF, Doro FG. A ruthenium polypyridyl complex with the antihypertensive drug valsartan: Synthesis, theoretical calculations and interaction studies with human serum albumin. Polyhedron 2016. [DOI: 10.1016/j.poly.2015.12.029] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
7
Skotnicki M, Apperley DC, Aguilar JA, Milanowski B, Pyda M, Hodgkinson P. Characterization of Two Distinct Amorphous Forms of Valsartan by Solid-State NMR. Mol Pharm 2015;13:211-22. [PMID: 26602457 DOI: 10.1021/acs.molpharmaceut.5b00646] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
8
Ardiana F, Indrayanto G. Valsartan. PROFILES OF DRUG SUBSTANCES, EXCIPIENTS, AND RELATED METHODOLOGY 2015;40:431-493. [PMID: 26051690 DOI: 10.1016/bs.podrm.2015.01.004] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
9
Vivian D, Cheng K, Khurana S, Xu S, Dawson PA, Raufman JP, Polli JE. Design and evaluation of a novel trifluorinated imaging agent for assessment of bile acid transport using fluorine magnetic resonance imaging. J Pharm Sci 2014;103:3782-3792. [PMID: 25196788 DOI: 10.1002/jps.24131] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2014] [Revised: 07/17/2014] [Accepted: 07/23/2014] [Indexed: 02/01/2023]
10
Skotnicki M, Aguilar JA, Pyda M, Hodgkinson P. Bisoprolol and bisoprolol-valsartan compatibility studied by differential scanning calorimetry, nuclear magnetic resonance and X-ray powder diffractometry. Pharm Res 2014;32:414-29. [PMID: 25115829 PMCID: PMC4300422 DOI: 10.1007/s11095-014-1471-7] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2014] [Accepted: 07/24/2014] [Indexed: 11/29/2022]
11
Cao C, Mao J, Li F, Yang M, He H, Jiang L, Liu M. Understanding the interaction between valsartan and detergents by NMR techniques and molecular dynamics simulation. J Phys Chem B 2012;116:7470-8. [PMID: 22708715 DOI: 10.1021/jp304304v] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
12
Bianchini RM, Castellano PM, Kaufman TS. Characterization of two new potential impurities of Valsartan obtained under photodegradation stress condition. J Pharm Biomed Anal 2011;56:16-22. [DOI: 10.1016/j.jpba.2011.04.017] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2011] [Revised: 04/16/2011] [Accepted: 04/18/2011] [Indexed: 11/30/2022]
13
Li F, Wang L, Xiao N, Yang M, Jiang L, Liu M. Dominant Conformation of Valsartan in Sodium Dodecyl Sulfate Micelle Environment. J Phys Chem B 2010;114:2719-27. [DOI: 10.1021/jp908958k] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
14
Identification of adulterants in a Chinese herbal medicine by LC-HRMS and LC-MS-SPE/NMR and comparative in vivo study with standards in a hypertensive rat model. J Pharm Biomed Anal 2009;51:705-11. [PMID: 19850434 DOI: 10.1016/j.jpba.2009.09.043] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2009] [Revised: 09/17/2009] [Accepted: 09/28/2009] [Indexed: 11/23/2022]
15
Potamitis C, Zervou M, Katsiaras V, Zoumpoulakis P, Durdagi S, Papadopoulos MG, Hayes JM, Grdadolnik SG, Kyrikou I, Argyropoulos D, Vatougia G, Mavromoustakos T. Antihypertensive Drug Valsartan in Solution and at the AT1 Receptor: Conformational Analysis, Dynamic NMR Spectroscopy, in Silico Docking, and Molecular Dynamics Simulations. J Chem Inf Model 2009;49:726-39. [DOI: 10.1021/ci800427s] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA